213 related articles for article (PubMed ID: 26683907)
1. Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Kuo MC; Chang SJ; Hsieh MC
Medicine (Baltimore); 2015 Dec; 94(50):e1570. PubMed ID: 26683907
[TBL] [Abstract][Full Text] [Related]
2. Gout can increase the risk of periodontal disease in Taiwan.
Chen HH; Ho CW; Hsieh MC; Chen CC; Hsu SP; Lin CL; Kao CH
Postgrad Med; 2020 Aug; 132(6):521-525. PubMed ID: 32298158
[No Abstract] [Full Text] [Related]
3. Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.
Chuang JP; Lee JC; Leu TH; Hidajah AC; Chang YH; Li CY
BMJ Open; 2019 Oct; 9(10):e028892. PubMed ID: 31601586
[TBL] [Abstract][Full Text] [Related]
4. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout.
Wang L; Sawhney M; Zhao Y; Carpio GR; Fonseca V; Shi L
Clin Ther; 2015 Jun; 37(6):1206-15. PubMed ID: 25857595
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract][Full Text] [Related]
6. Association between colchicine use and the risk of dementia among patients with gout: A nationwide retrospective cohort study.
Chen PY; Tseng CC; Lee YT; Yip HT; Chang R; Wei JC
Int J Rheum Dis; 2024 May; 27(5):e15162. PubMed ID: 38720421
[TBL] [Abstract][Full Text] [Related]
7. Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
Shah B; Toprover M; Crittenden DB; Jeurling S; Pike VC; Krasnokutsky S; Xia Y; Fisher MC; Slobodnick A; Tenner CT; Katz SD; Pillinger MH
Can J Cardiol; 2020 Nov; 36(11):1722-1728. PubMed ID: 32454073
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in Korean patients with gout.
Oh YJ; Lee YJ; Lee E; Park B; Kwon JW; Heo J; Moon KW
Korean J Intern Med; 2022 Mar; 37(2):460-467. PubMed ID: 32872748
[TBL] [Abstract][Full Text] [Related]
9. Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study.
Chu CC; Chen YC; Lin MH; Wu WT; Liu FC; Chen HC; Chou YC; Sun CA
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329085
[TBL] [Abstract][Full Text] [Related]
10. Impact of allopurinol on risk of myocardial infarction.
Grimaldi-Bensouda L; Alpérovitch A; Aubrun E; Danchin N; Rossignol M; Abenhaim L; Richette P;
Ann Rheum Dis; 2015 May; 74(5):836-42. PubMed ID: 24395556
[TBL] [Abstract][Full Text] [Related]
11. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.
Solomon DH; Liu CC; Kuo IH; Zak A; Kim SC
Ann Rheum Dis; 2016 Sep; 75(9):1674-9. PubMed ID: 26582823
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study.
Chen CJ; Hsieh MC; Liao WT; Chan YT; Chang SJ
Eur J Cancer Prev; 2016 May; 25(3):216-23. PubMed ID: 25830898
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific risk factors for incident gout: a prospective cohort study.
Chen JH; Yeh WT; Chuang SY; Wu YY; Pan WH
Clin Rheumatol; 2012 Feb; 31(2):239-45. PubMed ID: 21761146
[TBL] [Abstract][Full Text] [Related]
14. Gout after living kidney donation: a matched cohort study.
Lam NN; McArthur E; Kim SJ; Prasad GV; Lentine KL; Reese PP; Kasiske BL; Lok CE; Feldman LS; Garg AX; ;
Am J Kidney Dis; 2015 Jun; 65(6):925-32. PubMed ID: 25818677
[TBL] [Abstract][Full Text] [Related]
15. The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Rai SK; Aviña-Zubieta JA; McCormick N; De Vera MA; Shojania K; Sayre EC; Choi HK
Semin Arthritis Rheum; 2017 Feb; 46(4):451-456. PubMed ID: 28040245
[TBL] [Abstract][Full Text] [Related]
16. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
Kwon OC; Hong S; Ghang B; Kim YG; Lee CK; Yoo B
Am J Med; 2017 May; 130(5):583-587. PubMed ID: 28065770
[TBL] [Abstract][Full Text] [Related]
17. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Crittenden DB; Lehmann RA; Schneck L; Keenan RT; Shah B; Greenberg JD; Cronstein BN; Sedlis SP; Pillinger MH
J Rheumatol; 2012 Jul; 39(7):1458-64. PubMed ID: 22660810
[TBL] [Abstract][Full Text] [Related]
18. Contemporary epidemiology of gout in the UK general population.
Cea Soriano L; Rothenbacher D; Choi HK; García Rodríguez LA
Arthritis Res Ther; 2011 Mar; 13(2):R39. PubMed ID: 21371293
[TBL] [Abstract][Full Text] [Related]
19. Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis.
Wan H; Zeng L; Xiao R; Tang X; Shu Y; Shen S
Z Rheumatol; 2022 Aug; 81(6):501-506. PubMed ID: 35794279
[TBL] [Abstract][Full Text] [Related]
20. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
